Awakn Life Sciences
A biotechnology company with clinical operations, developing and delivering psychedelic therapeutics to better treat addiction. Learn more
Launch date
Employees
Market cap
CAD4.5m
Enterprise valuation
CAD4m (Public information from Feb 2024)
Share price
CAD0.19 AWKN.NE
Company register number 12767250
London England (HQ)
Authorizing premium user...